Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of extraesophageal manifestations of laryngopharyngeal reflux with Nexium 20 mg bid
2005-004532-43Phase 4Completed
- Sponsor
- LMU Klinikum
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in laryngopharyngeal reflux (LPR) comparing Esomeprazole 20 mg bid with Placebo (2 arms). Primary endpoint: Symptom score improvement at 3 months. Started Nov 2005; status: completed.
02
Drugs
esomeprazole
03
Conditions
laryngopharyngeal reflux (LPR)
Beyond the preview
Go deeper on 2005-004532-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004532-43.